Benitec Biopharma Inc. (BNTC) Shareholders’ equity 2019–2024
Benitec Biopharma Inc. (BNTC) shareholders’ equity at each fiscal year-end, per SEC filings.
$47.2MFY2024 · since FY2019: $16.6M → $47.2M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $47.2M | +23290.1% |
| FY2023 | $202,000 | -93.0% |
| FY2022 | $2.9M | -85.6% |
| FY2021 | $20.0M | +95.4% |
| FY2020 | $10.2M | -38.3% |
| FY2019 | $16.6M | — |
Source: SEC XBRL filings · For reference only · Not investment advice